We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Diagnostic Immunoassay Testing Made Effortless

By LabMedica International staff writers
Posted on 25 Nov 2010
A fully automated system for processing immunoassays is rapid, straightforward, more cost-effective and less labor intensive.

Project 24, quickly and easily processes 96-well microplates for total assay optimization. Project 24 is currently in the final stages of development, but not yet available for customer orders.

The New Dynex clinical diagnostics processing system for fully automated enzyme linked immunoassays (ELISA) testing is manufactured by Magellan Biosciences, (Chelmsford, MA, USA). A preview of the system was shown at MEDICA 2010 trade fair being held in Düsseldorf, Germany from November 17-20, 2010.

The manufacturers claim that the new system is a revolutionary approach to assay kit packaging. Rather than the manual reagent loading and data input of current systems, they have vastly simplified the process working with assay manufacturers to develop preloaded kits that the user adds directly from the box. The direct-load kit format eliminates the need for manual reagent transfer and includes a barcode system that electronically communicates all the information needed for a successful run. This eliminates manual data entry of kit-specific data, minimizes errors, and tracks all kit, sample, and consumable inventory so users are assured that when they walk away, the system will complete its work list fully.

Hiroshi Uchida, PhD, president and CEO of the company added, "Project 24 optimizes microplate ELISA testing by bringing true automation and extraordinary ease-of-use to what historically has been a tedious and time-consuming process. We have removed all of the manual set-up and data entry from the workflow, eliminating nearly 50 % of the hands-on time compared with traditional systems, significantly reducing cost of ownership as well as cost per test. Additionally, the Project 24 provides Magellan with a powerful platform for future development, including multiplexed immunoassay and molecular testing."

Related Links:

Magellan Biosciences




Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Latest Clinical Chem. News

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability